Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald J Atkins

Showing results (111-120 of 131) with videos related to

Pageof 14
Sort By:
The Journal of Steroid Biochemistry and Molecular Biology|November 7, 2017
Absence of vitamin D receptor in mature osteoclasts results in altered osteoclastic activity and bone lossYolandi Starczak, Daniel C Reinke, Kate R Barratt, et al.
Cancer Medicine|August 12, 2017
Anticancer efficacy of the hypoxia-activated prodrug evofosfamide is enhanced in combination with proapoptotic receptor agonists against osteosarcomaVasilios Liapis, Aneta Zysk, Mark DeNichilo, et al.
Biomaterials|June 30, 2006
The correlation of RANK, RANKL and TNFalpha expression with bone loss volume and polyethylene wear debris around hip implantsChristopher A Holding, David M Findlay, Roumen Stamenkov, et al.
The American Journal of Pathology|June 24, 2005
Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kappaBTeresa Morgan, Gerald J Atkins, Melanie K Trivett, et al.
Arthritis Research & Therapy|March 26, 2011
TWEAK and Fn14 expression in the pathogenesis of joint inflammation and bone erosion in rheumatoid arthritisAnak A S S K Dharmapatni, Malcolm D Smith, Tania N Crotti, et al.
Journal of Signal Transduction|June 1, 2012
A Bioinformatics Resource for TWEAK-Fn14 Signaling PathwayMitali Bhattacharjee, Rajesh Raju, Aneesha Radhakrishnan, et al.
Scientific Reports|November 20, 2021
Generation of two multipotent mesenchymal progenitor cell lines capable of osteogenic, mature osteocyte, adipogenic, and chondrogenic differentiationMatthew Prideaux, Christian S Wright, Megan L Noonan, et al.
Bone|February 22, 2021
Age and sex effects on FGF23-mediated response to mild phosphate challengeSamantha P Tippen, Megan L Noonan, Pu Ni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2006
TWEAK is a novel arthritogenic mediatorStuart J Perper, Beth Browning, Linda C Burkly, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 16, 2021
The HIF-PHI BAY 85-3934 (Molidustat) Improves Anemia and Is Associated With Reduced Levels of Circulating FGF23 in a CKD Mouse ModelMegan L Noonan, Pu Ni, Rafiou Agoro, et al.
Pageof 14

Showing results (111-120 of 131) with videos related to

Sort By:
Pageof 14
The Journal of Steroid Biochemistry and Molecular Biology|November 7, 2017
Absence of vitamin D receptor in mature osteoclasts results in altered osteoclastic activity and bone lossYolandi Starczak, Daniel C Reinke, Kate R Barratt, et al.
Cancer Medicine|August 12, 2017
Anticancer efficacy of the hypoxia-activated prodrug evofosfamide is enhanced in combination with proapoptotic receptor agonists against osteosarcomaVasilios Liapis, Aneta Zysk, Mark DeNichilo, et al.
Biomaterials|June 30, 2006
The correlation of RANK, RANKL and TNFalpha expression with bone loss volume and polyethylene wear debris around hip implantsChristopher A Holding, David M Findlay, Roumen Stamenkov, et al.
The American Journal of Pathology|June 24, 2005
Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kappaBTeresa Morgan, Gerald J Atkins, Melanie K Trivett, et al.
Arthritis Research & Therapy|March 26, 2011
TWEAK and Fn14 expression in the pathogenesis of joint inflammation and bone erosion in rheumatoid arthritisAnak A S S K Dharmapatni, Malcolm D Smith, Tania N Crotti, et al.
Journal of Signal Transduction|June 1, 2012
A Bioinformatics Resource for TWEAK-Fn14 Signaling PathwayMitali Bhattacharjee, Rajesh Raju, Aneesha Radhakrishnan, et al.
Scientific Reports|November 20, 2021
Generation of two multipotent mesenchymal progenitor cell lines capable of osteogenic, mature osteocyte, adipogenic, and chondrogenic differentiationMatthew Prideaux, Christian S Wright, Megan L Noonan, et al.
Bone|February 22, 2021
Age and sex effects on FGF23-mediated response to mild phosphate challengeSamantha P Tippen, Megan L Noonan, Pu Ni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2006
TWEAK is a novel arthritogenic mediatorStuart J Perper, Beth Browning, Linda C Burkly, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 16, 2021
The HIF-PHI BAY 85-3934 (Molidustat) Improves Anemia and Is Associated With Reduced Levels of Circulating FGF23 in a CKD Mouse ModelMegan L Noonan, Pu Ni, Rafiou Agoro, et al.
Pageof 14